Variant report
Variant | esv2462583 |
---|---|
Chromosome Location | chr2:31725621-31728793 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139262429 | chr2:31727601-31727602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576247495 | chr2:31727624-31727625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532303613 | chr2:31727626-31727627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534982364 | chr2:31727628-31727629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs472445 | chr2:31727639-31727640 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs394425 | chr2:31727675-31727676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs394434 | chr2:31727683-31727684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541325766 | chr2:31727712-31727713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369978969 | chr2:31727747-31727748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536065360 | chr2:31727771-31727772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563651037 | chr2:31727776-31727777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373440123 | chr2:31727797-31727798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554999155 | chr2:31727809-31727810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191190275 | chr2:31727810-31727811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182119022 | chr2:31727827-31727828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570071002 | chr2:31727828-31727829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537404979 | chr2:31727870-31727871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569725934 | chr2:31727901-31727902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7572232 | chr2:31727938-31727939 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs78790869 | chr2:31728000-31728001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs374878577 | chr2:31728052-31728053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs55732422 | chr2:31728139-31728140 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs148770335 | chr2:31728179-31728180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577591311 | chr2:31728201-31728202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533833 | chr2:31728286-31728287 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs535864103 | chr2:31728335-31728336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115391976 | chr2:31728351-31728352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs72866068 | chr2:31728368-31728369 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs545093951 | chr2:31728373-31728374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565048098 | chr2:31728391-31728392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186799939 | chr2:31728413-31728414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572661172 | chr2:31728432-31728433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs144867684 | chr2:31728459-31728460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561419678 | chr2:31728483-31728484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs370332480 | chr2:31728506-31728507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530464017 | chr2:31728523-31728524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191681640 | chr2:31728548-31728549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543655672 | chr2:31728559-31728560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74965241 | chr2:31728560-31728561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147933218 | chr2:31728596-31728597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs372794056 | chr2:31728597-31728598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552237331 | chr2:31728620-31728621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs141805873 | chr2:31728636-31728637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs115788477 | chr2:31728685-31728686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547611720 | chr2:31728764-31728765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567360258 | chr2:31728768-31728769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Cancer | 16751803 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Lung cancer | 16740712 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:31727600-31730800 | Enhancers | Fetal Intestine Large | intestine |
2 | chr2:31727600-31731600 | Enhancers | Fetal Intestine Small | intestine |
3 | chr2:31728600-31730200 | Enhancers | Duodenum Mucosa | Duodenum |